Glancy prongay & murray llp reminds investors of looming deadline in the class action lawsuit against acelrx pharmaceuticals, inc. (acrx)

Los angeles, july 23, 2021 /prnewswire/ --   glancy prongay & murray llp ("gpm") reminds investors of the upcoming  august 9, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired acelrx pharmaceuticals, inc. ("acelrx" or the "company") (nasdaq: acrx) securities between march 17, 2020 and february 12, 2021 , inclusive (the "class period"). if you suffered a loss on your acelrx investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/acelrx-pharmaceuticals-inc/.
ACRX Ratings Summary
ACRX Quant Ranking